Not Rated
|
Fund Size
(0.09% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 11-Nov-25 | 10009.60 | 0.10% | - | 0.61% | 179/229 |
| 1 Month | 17-Oct-25 | 10006.90 | 0.07% | - | 0.75% | 149/227 |
| 3 Month | 18-Aug-25 | 10090.80 | 0.91% | - | 3.65% | 191/222 |
| 6 Month | 16-May-25 | 11108.00 | 11.08% | - | 6.55% | 20/214 |
| YTD | 01-Jan-25 | 10392.70 | 3.93% | - | 5.56% | 107/201 |
| 1 Year | 18-Nov-24 | 11357.60 | 13.58% | 13.58% | 9.18% | 46/187 |
| Since Inception | 06-Feb-24 | 14557.00 | 45.57% | 23.43% | 14.36% | 18/199 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 18-Nov-24 | 12000 | 12925.25 | 7.71 % | 14.54 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 375.2 | 7.82% | 1.01% | 11.31% (Apr 2025) | 6.09% (Aug 2025) | 2.22 L | 32.89 k |
| Divis Laboratories Ltd. | Pharmaceuticals | 329.6 | 6.87% | 4.10% | 7.76% (May 2025) | 2.28% (Aug 2025) | 48.92 k | 27.34 k |
| J.b. Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals | 311.3 | 6.48% | -0.46% | 6.94% (Sep 2025) | 0% (Nov 2024) | 1.85 L | 5.43 k |
| Fortis Healthcare Ltd. | Hospital | 303.5 | 6.32% | -0.37% | 6.69% (Sep 2025) | 3.19% (Nov 2024) | 2.97 L | -8.55 k |
| Laurus Labs Ltd. | Pharmaceuticals | 224.6 | 4.68% | 0.40% | 4.68% (Oct 2025) | 2.18% (Jan 2025) | 2.36 L | 10.34 k |
| Cipla Ltd. | Pharmaceuticals | 201.4 | 4.20% | -0.36% | 8.07% (Feb 2025) | 4.2% (Oct 2025) | 1.34 L | 0.00 |
| Neuland Laboratories Ltd. | Pharmaceuticals | 183.6 | 3.82% | 0.62% | 3.82% (Oct 2025) | 1.3% (Feb 2025) | 11.14 k | 1.45 k |
| Lupin Ltd. | Pharmaceuticals | 179.2 | 3.73% | 0.59% | 5.58% (Mar 2025) | 1.15% (Jul 2025) | 91.24 k | 18.56 k |
| Sai Life Sciences Ltd. | Petrochemicals | 141.3 | 2.94% | 0.05% | 2.94% (Oct 2025) | 0% (Nov 2024) | 1.54 L | 5.35 k |
| Krishna Institute of Medical Sciences Ltd. | Hospital | 131 | 2.73% | -1.36% | 4.09% (Sep 2025) | 2.73% (Oct 2025) | 1.82 L | -0.77 L |
Investment / Portfolio Grades
| Security Type |
% Weight |
Category Average |
|---|---|---|
| Government Backed | 3.67% | 0.44% |
| Low Risk | 0.00% | 0.00% |
| Moderate Risk | 0.00% | 0.00% |
| High Risk | 0.00% | 0.00% |
| Very High Risk | 0.00% | 0.00% |
| Others | 0.00% | 0.00% |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 5.50% |
| Net Receivables | Net Receivables | -0.05% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
Out of 19 mutual fund schemes offered by this AMC, 2 is/are ranked 5 * , 2 is/are ranked 4 * , and 15 schemes are not ranked. See more about AMC